SCOPUS 정보 검색 플랫폼

World Journal of Gastroenterology

Volumn 18, Issue 14, 2012, Pages 1700-1702

Rifaximin for the prevention of spontaneous bacterial peritonitis

(4) Kalambokis, Georgios N a Mouzaki, Athanasia b Rodi, Maria b Tsianos, Epameinondas V a

a UNIVERSITY OF IOANNINA (Greece)

b UNIVERSITY OF PATRAS (Greece)

Author keywords

Ascites; Cirrhosis; Rifaximin; Spontaneous bacterial peritonitis

Indexed keywords

ENDOTOXIN; RIFAXIMIN;

ANTIBIOTIC THERAPY; ASCITES; ASCITES CELL; BACTERIAL PERITONITIS; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENDOTOXIN BLOOD LEVEL; HUMAN; INFECTION PREVENTION; LETTER; LEUKOCYTE COUNT; LIVER CIRRHOSIS; NEUTROPHIL COUNT; OBSERVATIONAL STUDY; RISK REDUCTION; SIDE EFFECT; SPONTANEOUS BACTERIAL PERITONITIS; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84860000638 PISSN: 10079327 EISSN: None Source Type: Journal
DOI: 10.3748/wjg.v18.i14.1700 Document Type: Letter

Times cited : (21)

References (5)

1
- 79955937051
- Diagnosis and therapy of ascites in liver cirrhosis
- Biecker E. Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol 2011; 17: 1237-1248
- (2011) World J Gastroenterol , vol.17 , pp. 1237-1248
- Biecker, E.¹

2
- 0034755537
- Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection
- Such J, Hillebrand DJ, Guarner C, Berk L, Zapater P, Westengard J, Peralta C, Soriano G, Pappas J, Runyon BA. Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection. Dig Dis Sci 2001; 46: 2360-2366
- (2001) Dig Dis Sci , vol.46 , pp. 2360-2366
- Such, J.¹ Hillebrand, D.J.² Guarner, C.³ Berk, L.⁴ Zapater, P.⁵ Westengard, J.⁶ Peralta, C.⁷ Soriano, G.⁸ Pappas, J.⁹ Runyon, B.A.¹⁰

3
- 74249111354
- Rifaximin: A unique gastrointestinalselective antibiotic for enteric diseases
- Koo HL, DuPont HL. Rifaximin: a unique gastrointestinalselective antibiotic for enteric diseases. Curr Opin Gastroenterol 2010; 26: 17-25
- (2010) Curr Opin Gastroenterol , vol.26 , pp. 17-25
- Koo, H.L.¹ Dupont, H.L.²

4
- 63849083717
- Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis
- Vlachogiannakos J, Saveriadis AS, Viazis N, Theodoropoulos I, Foudoulis K, Manolakopoulos S, Raptis S, Karamanolis DG. Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis. Aliment Pharmacol Ther 2009; 29: 992-999
- (2009) Aliment Pharmacol Ther , vol.29 , pp. 992-999
- Vlachogiannakos, J.¹ Saveriadis, A.S.² Viazis, N.³ Theodoropoulos, I.⁴ Foudoulis, K.⁵ Manolakopoulos, S.⁶ Raptis, S.⁷ Karamanolis, D.G.⁸

5
- 80053183783
- Long-term administration of rifaximin improves the prognosis of patients with alcohol-related decompensated cirrhosis: A case control study
- Vlachogiannakos J, Viazis N, Vasianopoulou P, Vafiadis-Zouboulis I, Karamanolis DG, Ladas SD. Long-term administration of rifaximin improves the prognosis of patients with alcohol-related decompensated cirrhosis: a case control study. Hepatology 2010: 328A
- (2010) Hepatology
- Vlachogiannakos, J.¹ Viazis, N.² Vasianopoulou, P.³ Vafiadis-Zouboulis, I.⁴ Karamanolis, D.G.⁵ Ladas, S.D.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.